Panganuron, Linda P.
HRN: 27-98-63 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/10/2026
METRONIDAZOLE 500MG (TAB)
04/10/2026
04/17/2026
PO
500mg
TID
H.Pylori
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: